In an effort to give you the best possible service, we would be grateful if you could take a few minutes of your time to answer a few questions.
My Saved Results
Join Our Mailing List
Home / Clinical Trials / Find Clinical Trials / A Phase I/IIa Multi-Dose Escalation Study to Evaluate Maximum...
I'm a new user and need a user account
Forgot your password?
This Phase I/IIa clinical study is to test safety and anti-tumor activity of BT062 to define the best dose in treating patients with relapsed or refractory multiple myeloma with multiple doses of BT062.
Winship Cancer Institute of Emory University1365 Clifton Road NEBuilding CAtlanta, GA 30322404-778-5180winshipcancer.emory.edu